{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:20Z","timestamp":1791923060467,"version":"4.3.4"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bladder cancer (BCa) is one of the most common malignant tumors of the urinary system. Its frequent recurrence, high metastatic potential, and resistance to therapies pose major obstacles to achieving long-term patient survival. As a core feature of tumor metabolic reprogramming, aerobic glycolysis (the Warburg effect) plays an essential role in the development of BCa. Current studies indicate that key glycolytic enzymes such as hexokinase 2 (HK2), pyruvate kinase M2 (PKM2), and lactate dehydrogenase A (LDHA) are abnormally expressed in BCa. These alterations in enzyme activity not only directly reshape energy metabolism but also exert non-metabolic functions, regulating tumor cell proliferation and invasion. Simultaneously, the aberrant activation of signaling pathways such as PI3K\/AKT\/mTOR and HIF-1\u03b1 further drives the glycolytic process. Moreover, the lactate produced through glycolysis leads to tumor microenvironment (TME) acidification, which facilitates extracellular matrix remodeling and immune evasion. In terms of treatment, strategies that directly target key glycolytic enzymes and indirectly intervene in the regulation of signaling pathways show promising application potential. Nevertheless, issues related to treatment-associated toxicity and the emergence of therapeutic resistance remain unresolved. This review systematically summarizes the characteristics of key enzymes in aerobic glycolysis, molecular regulatory mechanisms, and advancements in targeted therapy for BCa, aiming to provide new theoretical insights and directions for metabolic intervention and targeted therapy in BCa.<\/jats:p>","DOI":"10.3389\/fonc.2026.1799955","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:40:24Z","timestamp":1776832824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Mengyuan","family":"Pan","sequence":"first","affiliation":[{"name":"Graduate School, Henan Medical University","place":["Xinxiang, Henan, China"]},{"name":"Department of Urology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital","place":["Shanghai, China"]},{"name":"Graduate School, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Kong","sequence":"additional","affiliation":[{"name":"Experimental Cellular Therapy Group, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003254","article-title":"Global, regional, and national burden and trends of bladder cancer in individuals aged 55 years and older from 1990 to 2021: findings from the Global Burden of Disease Study 2021","volume":"111","author":"Li","year":"2025","journal-title":"Int J Surg (Lond Engl)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ (Clin Res Ed)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Updates: Rev Comment Antimicrob Anticancer Chemother"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1537808","article-title":"Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01504608","article-title":"\u00dcber den stoffwechsel der carcinomzelle","volume":"12","author":"Warburg","year":"1924","journal-title":"Naturwissenschaften"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/BF01712130","article-title":"Versuche an \u00fcberlebendem carcinom-gewebe","volume":"2","author":"Warburg","year":"1923","journal-title":"Klin Wochenschr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1284853","article-title":"Research progress on the mechanism of glycolysis in ovarian cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041532","article-title":"Understanding the warburg effect in cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/cancers15030982","article-title":"Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy","volume":"15","author":"Afonso","year":"2023","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s42003-024-07284-1","article-title":"SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway","volume":"8","author":"Gong","year":"2025","journal-title":"Commun Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12894-024-01444-5","article-title":"The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Urol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cellsig.2017.02.019","article-title":"Role of akt\/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes","volume":"34","author":"Houddane","year":"2017","journal-title":"Cell Signalling"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040909","article-title":"Role of PFKFB3 and PFKFB4 in cancer: genetic basis, impact on disease development\/progression, and potential as therapeutic targets","volume":"13","author":"Kotowski","year":"2021","journal-title":"Cancers"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31347","article-title":"The predictive value of PFKFB3 in bladder cancer prognosis","volume":"10","author":"Qiu","year":"2024","journal-title":"Heliyon"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"Zhu","year":"2021","journal-title":"Cancer Lett"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12158","article-title":"The role of the HIF\u20101\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-21-0403","article-title":"PKM2 is essential for bladder cancer growth and maintenance","volume":"82","author":"Xia","year":"2022","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205097","article-title":"UCHL1-PKM2 axis dysregulation is associated with promoted proliferation and invasiveness of urothelial bladder cancer cells","volume":"15","author":"Zheng","year":"2023","journal-title":"Aging (Milano)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.641432","article-title":"Dihydropyrimidinase like 2 promotes bladder cancer progression via pyruvate kinase M2-induced aerobic glycolysis and epithelial-mesenchymal transition","volume":"9","author":"Zou","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.174538","article-title":"Arsenic activated GLUT1-mTORC1\/HIF-1\u03b1-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells","volume":"947","author":"Fu","year":"2024","journal-title":"Sci Total Environ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2021.12.026","article-title":"ENO1 and cancer","volume":"24","author":"Huang","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2023.100750","article-title":"Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers","volume":"31","author":"Ni","year":"2023","journal-title":"Mol Ther Oncolytics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12967-022-03509-1","article-title":"Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer","volume":"20","author":"Huang","year":"2022","journal-title":"J Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41598-024-52573-8","article-title":"Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy","volume":"14","author":"Su","year":"2024","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-025-03325-7","article-title":"CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis","volume":"44","author":"Shen","year":"2025","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122974","article-title":"ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner","volume":"355","author":"Wang","year":"2024","journal-title":"Life Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217002","article-title":"N6-methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination","volume":"595","author":"Shen","year":"2024","journal-title":"Cancer Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145338","article-title":"Kr\u00fcppel-like factor 12 suppresses bladder cancer growth through transcriptionally inhibition of enolase 2","volume":"769","author":"Tang","year":"2021","journal-title":"Gene"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.15.4.636","article-title":"Two metabolic enzymes, LDH and FASN, serum levels in bladder cancer patients","volume":"15","author":"Fattahi","year":"2024","journal-title":"Casp J Intern Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/OTT.S358008","article-title":"CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-dependent glycolysis reprogramming","volume":"15","author":"Li","year":"2022","journal-title":"OncoTargets Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25257","article-title":"MCT1 regulates aggressive and metabolic phenotypes in bladder cancer","volume":"9","author":"Zhang","year":"2018","journal-title":"J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2024.03.001","article-title":"GLUT and HK: two primary and essential key players in tumor glycolysis","volume":"100","author":"Yadav","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063462","article-title":"Aberrantly glycosylated GLUT1 as a poor prognosis marker in aggressive bladder cancer","volume":"25","author":"Ferreira","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04805-0","article-title":"PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking","volume":"22","author":"Tan","year":"2024","journal-title":"J Transl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00997-z","article-title":"The YTHDC1\/GLUT3\/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression","volume":"55","author":"Yan","year":"2023","journal-title":"Exp Mol Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43046-022-00145-0","article-title":"Expression of GLUT4 and FAP in urothelial bladder carcinoma: correlation with angiogenesis and clinicopathological characteristics","volume":"34","author":"Abd El-Azeem","year":"2022","journal-title":"J Egypt Natl Cancer Inst"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70242","article-title":"PGK1 can affect the prognosis and development of bladder cancer","volume":"13","author":"Gao","year":"2024","journal-title":"Cancer Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28642","article-title":"ALDOLASE a regulates invasion of bladder cancer cells via E\u2010cadherin\u2010EGFR signaling","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100369","article-title":"Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the warburg effect","volume":"296","author":"Zhu","year":"2021","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jprot.2015.11.027","article-title":"Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer","volume":"132","author":"Peng","year":"2016","journal-title":"J Proteomics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107695","article-title":"TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation","volume":"215","author":"Wang","year":"2025","journal-title":"Pharmacol Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1156538","article-title":"Modulation of redox homeostasis: a strategy to overcome cancer drug resistance","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00719-3","article-title":"Lactate and lactylation in cancer: drivers of immune suppression and microenvironmental reprogramming","volume":"14","author":"Ji","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117553","article-title":"LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1","volume":"243","author":"Tang","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218282","article-title":"Lactylation enhances YTHDF3 stability to promote cisplatin resistance via m6A-dependent KDM6B decay in bladder cancer","volume":"642","author":"Yu","year":"2026","journal-title":"Cancer Lett"},{"key":"B51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41419-024-07241-0","article-title":"NOTCH3 promotes Malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K\/AKT pathway","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"Chi","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301095R","article-title":"POLR3G promotes EMT via PI3K\/AKT signaling pathway in bladder cancer","volume":"37","author":"Chen","year":"2023","journal-title":"FASEB J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23399","article-title":"Silencing of FGF6 hampers aerobic glycolysis and angiogenesis in bladder cancer by regulating PI3K\/akt and MAPK signaling pathways","volume":"37","author":"Zhi","year":"2023","journal-title":"J Biochem Mol Toxicol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3892\/ijo.2023.5532","article-title":"Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR\/PI3K\/AKT pathway","volume":"63","author":"Li","year":"2023","journal-title":"Int J Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13404","article-title":"YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer","volume":"56","author":"Su","year":"2023","journal-title":"Cell Proliferation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305922","article-title":"G3BP1 and SLU7 jointly promote immune evasion by downregulating MHC\u2010I via PI3K\/akt activation in bladder cancer","volume":"11","author":"Zheng","year":"2024","journal-title":"Adv Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2021.104665","article-title":"HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT\/mTOR pathway in bladder cancer","volume":"121","author":"Liu","year":"2021","journal-title":"Exp Mol Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061555","article-title":"Emerging roles for mammalian target of rapamycin (mTOR) complexes in bladder cancer progression and therapy","volume":"14","author":"Huan","year":"2022","journal-title":"Cancers"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2112006","article-title":"SMAR1 inhibits proliferation, EMT and warburg effect of bladder cancer cells by suppressing the activity of the wnt\/\u03b2-catenin signaling pathway","volume":"22","author":"Bao","year":"2023","journal-title":"Cell Cycle (Georget Tex)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.859707","article-title":"CNN1 represses bladder cancer progression and metabolic reprogramming by modulating HIF-1\u03b1 signaling pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-020-01613-y","article-title":"HIF-1\u03b1-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4","volume":"39","author":"Yu","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022110620","article-title":"IDH2 stabilizes HIF-1\u03b1-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer","volume":"42","author":"Shigeta","year":"2023","journal-title":"EMBO J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23725","article-title":"Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-\u03baB signaling pathway leads to the formation of a loop between HIF-1\u03b1 and MUC1-C promoting chemoresistance in bladder cancer","volume":"63","author":"Qing","year":"2024","journal-title":"Mol Carcinog"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119948","article-title":"Long non-coding RNAs as new players in bladder cancer: lessons from pre-clinical and clinical studies","volume":"288","author":"Mirzaei","year":"2022","journal-title":"Life Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-019-00285-x","article-title":"MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K\/AKT pathway","volume":"33","author":"Liu","year":"2020","journal-title":"Hum Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106475","article-title":"Crosstalk of miRNAs with signaling networks in bladder cancer progression: therapeutic, diagnostic and prognostic functions","volume":"185","author":"Hashemi","year":"2022","journal-title":"Pharmacol Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15806","article-title":"The long non\u2010coding RNA SNHG1 promotes bladder cancer progression by interacting with miR\u2010143\u20103p and EZH2","volume":"24","author":"Xiang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41420-023-01582-z","article-title":"Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p","volume":"9","author":"Zhong","year":"2023","journal-title":"Cell Death Discov"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23894","article-title":"CircST6GALNAC6 inhibits glycolysis of bladder cancer by regulating PRKN\/HK1 signaling pathway","volume":"64","author":"Zuo","year":"2025","journal-title":"Mol Carcinog"},{"key":"B72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-023-01856-1","article-title":"CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer","volume":"22","author":"Xie","year":"2023","journal-title":"Mol Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10142-022-00845-9","article-title":"Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer","volume":"22","author":"Mao","year":"2022","journal-title":"Funct Integr Genomics"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06446-7","article-title":"USP43 stabilizes c-myc to promote glycolysis and metastasis in bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/thno.102730","article-title":"DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10875-6","article-title":"m6A-YTHDF1 mediated regulation of GRIN2D in bladder cancer progression and aerobic glycolysis","volume":"63","author":"Le","year":"2025","journal-title":"Biochem Genet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12935-023-03160-w","article-title":"Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer","volume":"23","author":"Zhou","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Updates: Rev Comment Antimicrob Anticancer Chemother"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2015.111","article-title":"Targeting glycogen metabolism in bladder cancer","volume":"12","author":"Lew","year":"2015","journal-title":"Nat Rev Urol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju062","article-title":"Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease","volume":"106","author":"Guin","year":"2014","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01243-8","article-title":"Glycogen drives tumour initiation and progression in lung adenocarcinoma","volume":"7","author":"Clarke","year":"2025","journal-title":"Nat Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bcp.2014.09.001","article-title":"Glycogen metabolism in cancer","volume":"92","author":"Zois","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1109","article-title":"Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer","volume":"6","author":"Sahu","year":"2017","journal-title":"Cancer Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15047","article-title":"The warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets","volume":"112","author":"Burns","year":"2021","journal-title":"Cancer Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12672-024-01219-2","article-title":"A metabolic reprogramming-related gene signature correlates with prognosis and proliferation of BLCA","volume":"15","author":"Wu","year":"2024","journal-title":"Discov Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.695662","article-title":"Integrative transcriptomic, lipidomic, and metabolomic analysis reveals potential biomarkers of basal and luminal muscle invasive bladder cancer subtypes","volume":"12","author":"Feng","year":"2021","journal-title":"Front Genet"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2025.06.13","article-title":"Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer","volume":"37","author":"Facai","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European association of urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma In situ)\u2014a summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/cells13080699","article-title":"Breaking barriers: modulation of tumor microenvironment to enhance bacillus calmette\u2013gu\u00e9rin immunotherapy of bladder cancer","volume":"13","author":"Ibrahim","year":"2024","journal-title":"Cells"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1284344","article-title":"Histone lactylation regulates cancer progression by reshaping the tumor microenvironment","volume":"14","author":"Qu","year":"2023","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2025.2546219","article-title":"Hypoxia-induced PYCR1 regulates glycolysis and histone lactylation to promote bladder cancer progression and metastasis via SLC6A14\/Glutamine metabolism","volume":"26","author":"Li","year":"2025","journal-title":"Cancer Biol Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-023-02614-3","article-title":"HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway","volume":"42","author":"Lv","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13578-024-01333-2","article-title":"SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"9202","DOI":"10.24875\/CIRU.22000027","article-title":"La activaci\u00f3n del gen hypoxia inducible factor-1\u03b1 afect\u00f3 el microambiente del tumor e indujo la recurrencia e invasi\u00f3n del c\u00e1ncer de vejiga","volume":"90","author":"Chen","year":"2022","journal-title":"Cir Cir"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107078","article-title":"Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia","volume":"163","author":"Luo","year":"2023","journal-title":"Comput Biol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002710","article-title":"Cell softness reveals tumorigenic potential via ITGB8\/AKT\/glycolysis signaling in a mice model of orthotopic bladder cancer","volume":"137","author":"Qiu","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911747","article-title":"Monoamine oxidase inhibitors prevent glucose-dependent energy production, proliferation and migration of bladder carcinoma cells","volume":"23","author":"Resta","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155426","article-title":"Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1","volume":"126","author":"Liu","year":"2024","journal-title":"Phytomed Int J Phytother Phytopharm"},{"key":"B102","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s42003-025-08130-8","article-title":"Mannose inhibits PKM2 lactylation to induce pyroptosis in bladder cancer and activate antitumor immune responses","volume":"8","author":"Jin","year":"2025","journal-title":"Commun Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2025.J049","DOI":"10.1620\/tjem.2025.J049","article-title":"Oxymatrine inhibits PKM2-mediated glycolysis and enhances cisplatin sensitivity in bladder cancer","author":"Zhang","year":"2025","journal-title":"Tohoku J Exp Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12944-025-02431-x","article-title":"SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12967-021-03173-x","article-title":"TRIM38 triggers the ubiquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer","volume":"19","author":"Wang","year":"2021","journal-title":"J Transl Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41419-023-05770-8","article-title":"Melatonin inhibits bladder tumorigenesis by suppressing PPAR\u03b3\/ENO1-mediated glycolysis","volume":"14","author":"Shen","year":"2023","journal-title":"Cell Death Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2174\/1871520621666210726142814","article-title":"Anticancer effects of cinnamaldehyde through inhibition of ErbB2\/HSF1\/LDHA pathway in 5637 cell line of bladder cancer","volume":"22","author":"Aminzadeh","year":"2022","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3855368","DOI":"10.1155\/2022\/3855368","article-title":"Antitumor activities of aqueous cinnamon extract on 5637 cell line of bladder cancer through glycolytic pathway","volume":"2022","author":"Aminzadeh","year":"2022","journal-title":"Int J Inflammation"},{"key":"B109","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-015-0399-9","article-title":"3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants","volume":"14","author":"Konstantakou","year":"2015","journal-title":"Mol Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2036909","article-title":"Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)\/AKT pathway","volume":"13","author":"Hao","year":"2022","journal-title":"Bioengineered"},{"key":"B111","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4111\/icu.20240250","article-title":"Dasatinib induces apoptosis and autophagy by suppressing the PI3K\/akt\/mTOR pathway in bladder cancer cells","volume":"65","author":"Ho","year":"2024","journal-title":"Investig Clin Urol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3079823","DOI":"10.1155\/2022\/3079823","article-title":"Deoxyschizandrin inhibits the proliferation, migration, and invasion of bladder cancer cells through ALOX5 regulating PI3K-AKT signaling pathway","volume":"2022","author":"Chi","year":"2022","journal-title":"J Immunol Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23233","article-title":"Ropivacaine inhibits proliferation and invasion and promotes apoptosis and autophagy in bladder cancer cells via inhibiting PI3K\/AKT pathway","volume":"37","author":"Qiao","year":"2023","journal-title":"J Biochem Mol Toxicol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12894-022-01027-2","article-title":"Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K\/AKT\/mTOR pathway","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Urol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41598-023-50476-8","article-title":"Hesperetin promotes bladder cancer cells death via the PI3K\/AKT pathway by network pharmacology and molecular docking","volume":"14","author":"Lv","year":"2024","journal-title":"Sci Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4149\/gpb_2022013","article-title":"Induction of apoptosis through inactivation of ROS-dependent PI3K\/akt signaling pathway by platycodin D in human bladder urothelial carcinoma cells","volume":"41","author":"Park","year":"2022","journal-title":"Gen Physiol Biophys"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10854-x","article-title":"Cardamomin inhibits the proliferation and tumorigenesis of bladder cancer by ESR1 in PI3K\/AKT pathway","volume":"63","author":"Zhang","year":"2024","journal-title":"Biochem Genet"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01999-9","article-title":"SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis","volume":"40","author":"Tan","year":"2021","journal-title":"Oncogene"},{"key":"B119","doi-asserted-by":"publisher","first-page":"7714","DOI":"10.1038\/s41598-020-64880-x","article-title":"Vitamin K2 promotes PI3K\/AKT\/HIF-1\u03b1-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells","volume":"10","author":"Duan","year":"2020","journal-title":"Sci Rep"},{"key":"B120","article-title":"Anticancer effects of tanshinone IIA in bladder urothelial carcinoma by down-regulating aurora a, HIF-1\u03b1 and bcl-2 both in vitro and in vivo","volume":"37","author":"Faizan","year":"2024","journal-title":"Pak J Pharm Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2031677","article-title":"Magnesium isoglycyrrhizinate suppresses bladder cancer progression by modulating the miR-26b\/Nox4 axis","volume":"13","author":"Yuan","year":"2022","journal-title":"Bioengineered"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2023.2199188","article-title":"PLC\u03f5 promotes the warburg effect and tumorigenesis through AKT\/GSK3\u03b2\/Cdc25a in bladder cancer","volume":"40","author":"Fan","year":"2024","journal-title":"Biotechnol Genet Eng Rev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2902048","article-title":"PPP3CB inhibits cell proliferation and the warburg effect in bladder cancer by blocking PDHK1","volume":"29","author":"Qiu","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B124","article-title":"Exploring the correlation of glycolysis-related chondroitin polymerizing factor (CHPF) with clinical characteristics, immune infiltration, and cuproptosis in bladder cancer","volume":"13","author":"Zhong","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194568","article-title":"Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.07.015","article-title":"Nanotechnology-based tumor metabolic reprogramming: insights into nutrient-delivery and metabolism reactivation therapy","volume":"14","author":"Hu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00677","article-title":"Prognostic role of serum lactate dehydrogenase in patients with urothelial carcinoma: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109657","article-title":"Performance of 18F-FDG PET\/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/cells15040362","article-title":"Targeting glycolytic metabolism in cancer therapy: current approaches and future perspectives","volume":"15","author":"Li","year":"2026","journal-title":"Cells"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010169","article-title":"2-deoxyglucose transiently inhibits yeast AMPK signaling and triggers glucose transporter endocytosis, potentiating the drug toxicity","volume":"18","author":"Laussel","year":"2022","journal-title":"PloS Genet"},{"key":"B134","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12951-023-02175-9","article-title":"Mannose-doped metal-organic frameworks induce tumor cell pyroptosis via the PERK pathway","volume":"21","author":"Jin","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk7399","article-title":"Activation and antitumor immunity of CD8+ T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid","volume":"16","author":"Liu","year":"2024","journal-title":"Sci Transl Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.7150\/thno.74197","article-title":"TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1233620","article-title":"Up-regulated serum lactate dehydrogenase could become a poor prognostic marker in patients with bladder cancer by an evidence-based analysis of 2,182 patients","volume":"13","author":"Wei","year":"2023","journal-title":"Front Oncol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05872-z","article-title":"The role of 18F-FDG PET\/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma","volume":"49","author":"Wang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112951","article-title":"Assessing the performance of 18F-FDG PET\/CT in bladder cancer: a narrative review of current evidence","volume":"15","author":"Bacchiani","year":"2023","journal-title":"Cancers"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2023.02.004","article-title":"Added clinical value of 18F-FDG-PET\/CT to stage patients with high-risk non-muscle invasive bladder cancer before radical cystectomy","volume":"21","author":"Van Ginkel","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040606","article-title":"PET imaging in bladder cancer: an update and future direction","volume":"16","author":"Zhang-Yin","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02113-9","article-title":"Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective","volume":"23","author":"Xiao","year":"2024","journal-title":"Mol Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114381","article-title":"Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder cancer","volume":"152","author":"Li","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.123647","article-title":"Metabolic reprogramming in urological tumors: new perspectives from tumor metabolic phenotypes to therapeutic targets","volume":"21","author":"Li","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1430583","article-title":"Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer","volume":"15","author":"Shen","year":"2025","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051145","article-title":"Targeting metabolic reprogramming in bladder cancer immunotherapy: a precision medicine approach","volume":"13","author":"Liu","year":"2025","journal-title":"Biomedicines"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1799955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:40:36Z","timestamp":1776832836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1799955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":146,"alternative-id":["10.3389\/fonc.2026.1799955"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1799955","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1799955"}}